Written by Tyler R. Etter
On November 19, the Food and Drug Administration (FDA) released two new guidance documents for genetically engineered (GE) plants and animals for use as food. One document is the finalized guidance on labeling food to indicate if food has or has not been derived from GE plants. The other document is draft guidance on voluntary labeling indicating if food has or has not been derived from GE Atlantic salmon.
On November 19, the Food and Drug Administration (FDA) released two new guidance documents for genetically engineered (GE) plants and animals for use as food. One document is the finalized guidance on labeling food to indicate if food has or has not been derived from GE plants. The other document is draft guidance on voluntary labeling indicating if food has or has not been derived from GE Atlantic salmon.
The first document, pertaining to plant-derived food products, is meant to assist food and feed manufacturers that wish to apply
labels to their products. The FDA’s primary concern is that any label is
truthful and not misleading. For foods that do not use GE derived foods,
labeling such include a statement in a context that clearly refers to
bioengineering, such as “Not bioengineered” or “Not genetically engineered”,
among other possibilities. Foods that are derived from GE products must have
statements such as “Genetically engineered” or similar declarations. The FDA
does not encourage the use of “GMO” or “genetic modification” as such claims
are very broad, and encompass a wide variety of alterations, including natural
breeding methods.
The second document, pertaining to food derived from GE Atlantic salmon, was released in conjunction with the approval of AquAdvantage
Salmon, a GE Salmon from AquaBounty Technologies. The guidance recommends
labeling standards similar to the GE plant guidance, with clear context for the
labeling directly stating an association or lack thereof with bioengineering.
No comments:
Post a Comment